Table 1.
The characteristics of the enrolled individuals.
| ATB | LTBI | HC | P-value* | |
|---|---|---|---|---|
| Numbers of subjects | 66 | 16 | 22 | / |
| Average age, years (range) | 42.8 (18–82) | 35.9 (25–58) | 34.6 (22–67) | 0.0589 |
| Gender, male/female | 40/26 | 8/8 | 7/15 | 0.0623 |
| History of BCG vaccination, n (%) | 58 (87.9) | 16 (100.0) | 22 (100.0) | 0.1210 |
| History of exposure to ATB, n (%) | 2 (3.0) | 4 (25.0) | 6 (27.3) | 0.0016 |
| Sputum AFB smear or culture positive, n (%) | 66 (100.0) | / | / | / |
| Duration of anti-TB therapy at enrollment, average days (range) | 8.1 (1–28) | / | / | / |
ATB, active tuberculosis; LTBI, latent tuberculosis infection; HC, healthy control; BCG, bacillus Calmette-Guerin; AFB, acid-fast bacilli; TB, tuberculosis.
*
Compared among ATB, LTBI, and HC groups.